Back
Compare AU
Compare DRUG vs. QRE
Compare shares and ETFs on the ASX that you can trade on Pearler.
Overview
When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the Betashares Global Healthcare Currency Hedged ETF (DRUG) and the Betashares Australian Resources Sector ETF (QRE). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.
Community Stats
DRUG | QRE | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 75 | 127 |
Median incremental investment | $742.79 | $993.50 |
Median investment frequency | Monthly | Monthly |
Median total investment | $1,810.48 | $2,313.92 |
Average age group | > 35 | > 35 |
Key Summary
DRUG | QRE | |
|---|---|---|
Strategy | DRUG.AX was created on 2016-08-04 by BetaShares. The fund's investment portfolio concentrates primarily on health care equity. DRUG.AX aims to track the performance of an index (before fees and expenses) that comprises the largest global healthcare companies (ex-Australia), hedged into Australian dollars. | QRE.AX was created on 2010-12-10 by BetaShares. The fund's investment portfolio concentrates primarily on theme equity. QRE.AX aims to track the performance an index (before fees and expenses) comprising the largest ASX-listed companies in the resources sector, including BHP, Rio Tinto, Woodside Petroleum and more. |
Top 3 holdings | AUD - AUSTRALIA DOLLAR (0 %) BRL - BRAZILIAN REAL (0 %) CHF - SWISS FRANC (0 %) | S&P/ASX 200 R IDX JUN26 (0 %) BHP GROUP LTD (35.84 %) WOODSIDE ENERGY GROUP LTD (8.37 %) |
Top 3 industries | Other (75.91 %) Communication Services (33.53 %) Health Care (23.80 %) | Materials (73.55 %) Energy (18.66 %) Utilities (3.92 %) |
Top 3 countries | United States (69.91 %) Switzerland (10.93 %) United Kingdom of Great Britain and Northern Ireland (7.38 %) | Australia (95.29 %) United States (3.12 %) United Kingdom of Great Britain and Northern Ireland (0.81 %) |
Management fee | 0.57 % | 0.34 % |
Key Summary
DRUG | QRE | |
|---|---|---|
Issuer | BetaShares | BetaShares |
Tracking index | Nasdaq Global ex-Australia Healthcare Hedged AUD Index - AUD | Solactive Australia Resources Sector Index - AUD - Benchmark TR Gross |
Asset class | ETF | ETF |
Management fee | 0.57 % | 0.34 % |
Price | $8.54 | $10.33 |
Size | $163.973 million | $466.722 million |
10Y return | N/A | 193.47 % |
Annual distribution yield (5Y) | 1.92 % | 6.49 % |
Market | ASX | ASX |
First listed date | 08/08/2016 | 15/12/2010 |
Purchase fee | $6.50 | $6.50 |
Community Stats
DRUG | QRE | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 75 | 127 |
Median incremental investment | $742.79 | $993.50 |
Median investment frequency | Monthly | Monthly |
Median total investment | $1,810.48 | $2,313.92 |
Average age group | > 35 | > 35 |
Pros and Cons
DRUG | QRE | |
|---|---|---|
Pros |
|
|
Cons |
|
|
DRUG | QRE |
|---|---|
Lower exposure to AU market | Higher exposure to AU market |
Higher exposure to US market | Lower exposure to US market |
Higher management fee | Lower management fee |
Lower price growth | Higher price growth |
Lower distribution yield | Higher distribution yield |